Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab in Chronic Spontaneous Urticaria

View source ↗

Summary

This clinical trial update indicates ongoing enrollment for a study investigating how diet and oxidative stress affect disease severity and the response to omal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xolair (omalizumab)

Snippet

Sponsor: Istanbul Training and Research Hospital | Conditions: Chronic Spontaneous Urticaria (CSU) | Status: ENROLLING_BY_INVITATION